CD36 and Hyperglycemia: Our data suggests that CD36 deficiency in Nrf2-deficient mice is a powerful antiatherogenic factor, which can override multiple pro-atherogenic conditions, which were present in the ApoE−/−Nrf2−/− mice, including oxidative stress, hypertriglyceridemia and hyperglycemia.